Compositions comprising phosphodiesterase inhibitors for use in the treatment of a solid tumor in a human patient
AssigneeSartar Therapeutics Ltd
InventorsHarri Sihto, Olli-Pekka Pulkka, Olli Kallioniemi, Heikki Joensuu
Life of this patent
Estimating the term…
Abstract
The present invention is related to a composition comprising a phosphodiesterase inhibitor, such as anagrelide or a salt thereof, for use in the treatment of a solid tumor, such as gastrointestinal stromal tumor (GIST) or a liposarcoma, which express phosphodiesterase 3 enzymes, in a human patient.
Claims17
-27. (canceled)
A method for treatment of a phosphodiesterase 3A and/or phosphodiesterase 3B enzyme expressing solid tumor in a human patient, wherein a pharmaceutically effective amount of a composition comprising anagrelide or a salt thereof is administered to a patient in need of such treatment.
A method for treatment of gastrointestinal stromal tumor (GIST) or liposarcomas in a human patient, wherein a pharmaceutically effective amount of a composition comprising a phosphodiesterase 3 inhibitor is administered to a patient in need of such treatment.
Dependencies are inferred from the claim text.